WASHINGTON, March 10 (Reuters) - The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results